Revance Therapeutics (NASDAQ:RVNC) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research note released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. RVNC has been the subject of several other reports. Stifel Nicolaus lowered their target price on Revance Therapeutics from $24.00 to $20.00 and set […]
More Stories
PennantPark Investment Co. (PNNT) to Issue Monthly Dividend of $0.08 on November 1st
PennantPark Investment Co. (NASDAQ:PNNT – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, Wall Street Journal reports....
Global X SuperDividend REIT ETF (NASDAQ:SRET) to Issue Monthly Dividend of $0.16
Global X SuperDividend REIT ETF (NASDAQ:SRET – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, NASDAQ reports....
Cohen & Steers Select Preferred and Income Fund, Inc. (PSF) to Issue Monthly Dividend of $0.13 on November 29th
Cohen & Steers Select Preferred and Income Fund, Inc. (NYSE:PSF – Get Free Report) announced a monthly dividend on Wednesday,...
Gear Energy Ltd. Plans Monthly Dividend of $0.01 (TSE:GXE)
Gear Energy Ltd. (TSE:GXE – Get Free Report) announced a monthly dividend on Wednesday, October 2nd, Zacks reports. Investors of...
Cohen & Steers Infrastructure Fund, Inc (UTF) To Go Ex-Dividend on November 12th
Cohen & Steers Infrastructure Fund, Inc (NYSE:UTF – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, Wall...
NovaGold Resources (NYSEAMERICAN:NG) Announces Quarterly Earnings Results
NovaGold Resources (NYSEAMERICAN:NG – Get Free Report) (TSE:NG) issued its quarterly earnings results on Wednesday. The mining company reported ($0.03)...